Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2026-09-03 16:17:38 ET · period of report 2026-09-01 · accession 0001724311-26-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-03 16:17 | 2026-09-01 | DNLI | Schuth Alexander O. | COFO, Sec | S - Sale | $23.44 | -2,768 | 279.0K | -1.0% | -$64.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | S | D | 2,768 | $23.44 | 278,995 | D | — | — | (F1) The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2026. (F2) Includes 135,475 Unvested RSUs. |